The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies. While many biotech stocks have struggled this year ...

Insider asked 12 venture capitalists which biotech startups would take off in the next year. Here are the 10 startups they named that are located in the Boston area. They're attempting to ...

Curtis Cole is a leader of the Boston Life Science ... representing life science companies providing thoughtful strategies across the life science, pharmaceutical and biomanufacturing sectors.

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

These systems and the humans training them have yet to put a single treatment into pharmacies, said Jen Nwankwo, CEO of 1910 Genetics, a biotech company headquartered in Boston’s Seaport District.

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

A Nurturing Force in Boston's Biotech Ecosystem Cambridge Scientific has emerged as a trusted partner in the region's booming biotech industry. Founded in 1997 by CEO Barb Pearlman, the company's ...

A few weeks after releasing disappointing data from its norovirus vaccine trial, a Boston biotech is cutting its workforce. A few weeks after releasing disappointing data from its norovirus ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

The Triangle has become one of the most attractive markets for biotech investments since the pandemic due to its talented workforce and its lower cost than more established markets, like Boston or ...

An international pharmaceutical research company will lay off 83 Boston-area employees by the end of June, according to new filings with the state. Ono Pharma, the United States subsidiary of a ...

In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...